Literature DB >> 27791278

Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells Reverse Insulin Resistance in Cellular Models.

Nitya Shree1, Ramesh R Bhonde1.   

Abstract

The link between insulin resistance (IR) and type 2 diabetes has been recognized for a long time. Type 2 diabetes is often associated with basal hyperinsulinemia, reduced sensitivity to insulin, and disturbances in insulin release. There are evidences showing the reversal of IR by mesenchymal stem cells. However, the effect of conditioned media from adipose derived mesenchymal stem cells (ADSCs-CM) in reversal of IR has not been established. We established an insulin resistant model of 3T3L1 and C2C12 cells and treated with ADSCs-CM. 2-NBDG (2-[N-[7-Nitrobenz-2-oxa-1,3-diazol-4-yl]Amino]-2-Deoxyglucose) uptake was performed to assess improvement in glucose uptake. Genes involved in glucose transport and in inflammation were also analysed. Western blot for glucose transporter-4 and Akt was performed to evaluate translocation of Glut4 and insulin signaling respectively. We found that the ADSCs-CM treated cells restored insulin, stimulated glucose uptake as compared to the untreated control indicating the insulin sensitizing effect of the CM. The treated cells also showed inhibition adipogenesis in 3T3L1 cells and significant reduction of intramuscular triglyceride accumulation in C2C12 cells. Gene expressions studies revealed the drastic upregulation of GLUT4 gene and significant reduction in IL6 and PAI1 gene in both 3T3L1 and C2C12 cells, indicating possible mechanism of glucose uptake with concomitant decrease in inflammation. Enhancement of GLUT4 and phospho Akt protein expression seems to be responsible for the increment in glucose uptake and enhanced insulin signaling, respectively. Our study revealed for the first time that ADSCs-CM acts as an alternative insulin sensitizer providing stem cell solution to IR. J. Cell. Biochem. 118: 2037-2043,2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADIPOSE DERIVED MESENCHYMAL STEM CELLS; CONDITIONED MEDIA; GLUCOSE UPTAKE; INSULIN RESISTANCE

Mesh:

Substances:

Year:  2017        PMID: 27791278     DOI: 10.1002/jcb.25777

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth.

Authors:  Makoto Horikawa; Shinichiro Koizumi; Tomoya Oishi; Taisuke Yamamoto; Masashi Ikeno; Masahiko Ito; Tomohiro Yamasaki; Shinji Amano; Tetsuro Sameshima; Yasuyuki Mitani; Yoshihiro Otani; Yuanqing Yan; Tetsuro Suzuki; Hiroki Namba; Kazuhiko Kurozumi
Journal:  Cancer Gene Ther       Date:  2022-09-08       Impact factor: 5.854

2.  Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes.

Authors:  Mengmeng Wang; Lili Song; Charlie Strange; Xiao Dong; Hongjun Wang
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

3.  Mesenchymal stem cell conditioned medium ameliorates diabetic serum-induced insulin resistance in 3T3-L1 cells.

Authors:  Avinash Sanap; Ramesh Bhonde; Kalpana Joshi
Journal:  Chronic Dis Transl Med       Date:  2020-10-22

Review 4.  Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?

Authors:  Agnieszka Mikłosz; Barbara Emilia Nikitiuk; Adrian Chabowski
Journal:  Obes Rev       Date:  2022-01-05       Impact factor: 10.867

5.  Determination of optimized oxygen partial pressure to maximize the liver regenerative potential of the secretome obtained from adipose-derived stem cells.

Authors:  Sang Chul Lee; Kee-Hwan Kim; Ok-Hee Kim; Sang Kuon Lee; Ha-Eun Hong; Seong Su Won; Sang-Jin Jeon; Byung Jo Choi; Wonjun Jeong; Say-June Kim
Journal:  Stem Cell Res Ther       Date:  2017-08-03       Impact factor: 6.832

Review 6.  Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes.

Authors:  Yicheng Qi; Jing Ma; Shengxian Li; Wei Liu
Journal:  Stem Cell Res Ther       Date:  2019-08-28       Impact factor: 6.832

7.  Effects and mechanism of stem cells from human exfoliated deciduous teeth combined with hyperbaric oxygen therapy in type 2 diabetic rats.

Authors:  Yifeng Xu; Jin Chen; Hui Zhou; Jing Wang; Jingyun Song; Junhao Xie; Qingjun Guo; Chaoqun Wang; Qin Huang
Journal:  Clinics (Sao Paulo)       Date:  2020-06-03       Impact factor: 2.365

8.  Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity.

Authors:  Hui-Lan Tan; Xiao-Hui Guan; Min Hu; Jie Wu; Rong-Zhen Li; Ling-Fang Wang; Hou-Da Huang; Zhen-Ping Yu; Xiao-Yu Wang; Yun-Fei Xiao; Ke-Yu Deng; Hong-Bo Xin
Journal:  Stem Cell Res Ther       Date:  2021-06-26       Impact factor: 6.832

Review 9.  Mesenchymal stem cell therapy in type 2 diabetes mellitus.

Authors:  Li Zang; Haojie Hao; Jiejie Liu; Yijun Li; Weidong Han; Yiming Mu
Journal:  Diabetol Metab Syndr       Date:  2017-05-15       Impact factor: 3.320

10.  Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models.

Authors:  Hyeon-Jin Kim; Qiang Li; Woo-Jin Song; Hye-Mi Yang; Su-Yeon Kim; Sang-Chul Park; Jin-Ok Ahn; Hwa-Young Youn
Journal:  BMC Vet Res       Date:  2018-11-16       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.